Are you getting the best rate from your broker?
Compare your broker's rates now to find out if you can save money

Choose your broker below
Welcome to Dividend.com. Please help us personalize your experience.

Select the one that best describes you
Dividend logo

The news from Pfizer Inc. (PFE ) at the end of last November landed like a bomb.

The New York-based pharmaceutical giant announced that it would buy Botox manufacturer Allergan Plc (AGN ) in a deal worth $160 billion, making the combined company the largest drugmaker in the world.

A Complex Merger

However, the size of the deal – or even the size of the new corporate behemoth – wasn’t what made it notable. The acquisition involved a complicated legal dance in which Allergan would technically buy Pfizer and the company’s headquarters would be moved to Ireland, even though the new company would actually be run by Pfizer executives in New York.

To read the Full Story, Go Premium or Log In

Popular Articles

Premium Shutterstock 697566253

The Republican Tax Plan: Your Dividend Stock’s Best Friend

The biggest piece of news for investors isn’t the state of the economy or even recent trade...

Premium Shutterstock 19639918

The Market Wrap for March 16: Bears Prevail Despite Slowing Inflation

Bears continued to rule the market this week amid political turmoil in Washington, the forecast...


Trending: Aluminum and Steel in Spotlight as Trump Signs Watered Down Tariff Order

Dividend.com analyzes the search patterns of our visitors each week. By sharing these trends with...